Results 141 to 150 of about 13,041 (208)

Global Polio Eradication Initiative : annual report 2016 : eradication within reach\ue2\u20ac\ua6

In 2016, fewer children were paralysed by polio than in any other year in history, and the world moved closer still to eradicating polio. Circulating in a few areas of Pakistan, Afghanistan and Nigeria, wild poliovirus (WPV) is more geographically ...

core  

National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004-2019 demographic surveillance data in rural Bangladesh. [PDF]

EClinicalMedicine, 2021
Nielsen S, Khalek MA, Benn CS, Aaby P, Hanifi SMA.   +4 more
europepmc   +1 more source

Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine. [PDF]

NPJ Vaccines, 2021
Thiel N, Selwyn C, Murphy G, Simpson S, Chakrabarti AC.   +4 more
europepmc   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency. [PDF]

Pathogens
Kurji FD, Bandyopadhyay AS, Zipursky S, Cooper LV, Gast C, Toher M, Clemens R, Clemens SAC, Prasad R, Azhari A.   +9 more
europepmc   +1 more source

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial. [PDF]

Vaccine, 2021
Zaman K, Kovacs SD, Vanderende K, Aziz A, Yunus M, Khan S, Snider CJ, An Q, Estivariz CF, Oberste MS, Pallansch MA, Anand A.   +11 more
europepmc   +1 more source

Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria. [PDF]

J Infect Dis
Voorman A, Lyons H, Shuaib F, Adamu US, Korir C, Erbeto T, Bandyopadhyay AS, Okiror S.   +7 more
europepmc   +1 more source

The case for replacing live oral polio vaccine with inactivated vaccine in the Americas. [PDF]

Lancet, 2020
Alfaro-Murillo JA, Ávila-Agüero ML, Fitzpatrick MC, Crystal CJ, Falleiros-Arlant LH, Galvani AP.   +5 more
europepmc   +1 more source

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.

Vaccine, 2023
Macklin GR, Peak C, Eisenhawer M, Kurji F, Mach O, Konz J, Gast C, Bachtiar NS, Bandyopadhyay AS, Zipursky S, nOPV2 Working Group.   +10 more
europepmc   +1 more source